Interactions of human serum albumin with meloxicam: Characterization of binding site

Journal of Pharmaceutical and Biomedical Analysis

Volumn 52, Issue 2, 2010, Pages 300-304

  Trynda Lemiesz, Lilianna ^a,b   Wiglusz, Katarzyna ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY OF WROC AW   (Poland)

Author keywords

Aspirin; Circular dichroism; Fluorescence; Human serum albumin; Meloxicam

Indexed keywords

ACETYLSALICYLIC ACID; HUMAN SERUM ALBUMIN; MELOXICAM; TRYPTOPHAN; WARFARIN;

AQUEOUS SOLUTION; ARTICLE; BINDING AFFINITY; BINDING SITE; CIRCULAR DICHROISM; CONFORMATION; CONTROLLED STUDY; DRUG BINDING; DRUG PROTEIN BINDING; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; FLUORESCENCE SPECTROSCOPY; HYDROPHOBICITY; LIGAND BINDING; PH; PHOTOCHEMICAL QUENCHING; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BILIRUBIN; BINDING SITES; CIRCULAR DICHROISM; HUMANS; HYDROGEN-ION CONCENTRATION; LIGANDS; MOLECULAR STRUCTURE; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; SERUM ALBUMIN; SPECTROMETRY, FLUORESCENCE; THIAZINES; THIAZOLES; WARFARIN; WATER;

EID: 77349109245     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.12.025     Document Type: Article

References (29)

1. Peters T.Jr. All about Albumin 1996, Academic Press, Inc., San Diego, CA.
2. Carter D.C., Ho J.X. Adv. Protein Chem. 1994, 45:153-203.
3. Sudlow G., Birkett D.J., Wade D.N. Mol. Pharmacol. 1975, 11:824-832.
4. Fasano M., Curry S., Terreno E., Galliano M., Fanali G., Narciso P., Notari S., Ascenzi P. IUBMB Life 2005, 57:787-796.
5. Petitpas I., Bhattacharya A.A., Twine S., East M., Curry S. J. Biol. Chem. 2001, 276:22804-22809.
6. Baroni S., Mattu M., Vannini A., Cipollone R., Aime S., Ascenzi P., Fasano M. Eur. J. Biochem. 2001, 268:6214-6220.
7. Dockal M., Carter D.C., Rukert F. J. Biol. Chem. 1999, 274:29303-29310.
8. Petersen C.E., Ha C.-E., Harohalli K., Feix J.B., Bhagavan N.V. J. Biol. Chem. 2000, 275:20985-20995.
9. Dannhardt G., Kiefer W. Eur. J. Med. Chem. 2001, 36:109-126.
10. Laird J.M.A., Herrero J.F., Garcia de la Rubia P., Cervero F. Inflamm. Res. 1996, 46:203-210.
11. Turck D., Roth W., Busch U. Br. J. Rheumatol. 1996, 35:13-16.
12. Banerjee R., Sarkar M. Luminescence 2002, 99:255-263.
13. Singla A.K., Chawla M., Singh A. J. Pharm. Pharmacol. 2000, 52:467-486.
14. Davies N.M., Skjodt N.M. Clin. Pharmacokinet. 1999, 36:115-119.
15. Jolliet P., Simon N., Bree F., Urien S., Pagliara A., Carrupt P.A., Testa B., Tillement J.P. Pharm. Res. 1997, 14:650-656.
16. Bae J.-W., Kim M.-J., Jang Ch-G., Lee S.-Y. J. Chromatogr. B 2007, 859:69-73.
17. Seedher N., Bhatia S. J. Pharm. Biomed. Anal. 2005, 39:257-262.
18. Seedher N., Bhatia S., Singh B. Chem. Biol. Drug Design 2008, 7:297-302.
19. Beaven G.H., Chen S.H., d'Albis A., Gratzer W.B. Eur. J. Biochem. 1974, 41:539-546.
20. Eftink M.R., Ghiron C.A. Biochemistry 1976, 15:672-680.
21. He X.M., Carter D.C. Nature 1992, 358:209-215.
22. Neault J.F., Novetta-Delen A., Arakawa H., Malonga H., Tajmir-Riahi H.A. Can. J. Chem. 2000, 78(2):291-296.
23. Togashi D.M., Ryder A.G. Fluoresc. 2008, 18:519-526.
24. Bagatolli L.A., Kivatinitz S.C., Fidelio G.D. J. Pharm. Sci. 1996, 85:1131-1132.
25. Bos O.J., Remijn J.P., Fisher E., Witing J., Janssen L.H. Biochem. Pharmacol. 1988, 37:3905-3909.
26. Wardell M., Wang Z., Ho J.X., Robert J., Ruuker F., Ruble J., Carter D.C. Biochem. Biophys. Res. Commun. 2002, 291:813-819.
27. Fitos I., Visy J., Kardos J. Chirality 2002, 14:442-448.
28. Lightner D.A., Reisinger M., Landen G.L. J. Biol. Chem. 1986, 261:6034-6038.
29. Chen R.F. Arch. Biochem. Biophys. 1974, 160:106-112.